Split History
ETFs Holding IRWD »    IRWD Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Ironwood Pharmaceuticals is a gastrointestinal (GI), healthcare company focusing on developing the treatment of GI diseases. Co.'s commercial product, LINZESS® (linaclotide), a guanylate cyclase type C agonists, is indicated for adult men and women suffering from irritable bowel syndrome with constipation, or chronic idiopathic constipation. In addition, Co. is developing MD-7246, an oral, intestinal, non-opioid, pain-relieving agent for patients with abdominal pain associated with certain GI diseases. Co. is also developing IW-3718, a gastric retentive formulation of a bile acid sequestrant for the potential treatment of refractory gastroesophageal reflux disease. According to our IRWD split history records, Ironwood Pharmaceuticals has had 1 split.
IRWD split history picture
Ironwood Pharmaceuticals (IRWD) has 1 split in our IRWD split history database. The split for IRWD took place on April 02, 2019. This was a 1194 for 1000 split, meaning for each 1000 shares of IRWD owned pre-split, the shareholder now owned 1194 shares. For example, a 1000 share position pre-split, became a 1194 share position following the split.

When a company such as Ironwood Pharmaceuticals splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the IRWD split history from start to finish, an original position size of 1000 shares would have turned into 1194 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ironwood Pharmaceuticals shares, starting with a $10,000 purchase of IRWD, presented on a split-history-adjusted basis factoring in the complete IRWD split history. IRWD split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/14/2011
End date: 04/13/2021
Start price/share: $12.99
End price/share: $10.31
Dividends collected/share: $0.00
Total return: -20.63%
Average Annual Total Return: -2.28%
Starting investment: $10,000.00
Ending investment: $7,939.25
Years: 10.01
Date Ratio
04/02/20191194 for 1000
IRWD is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ISRG Split History
ITUS Split History
IVC Split History
JAGX Split History
JNJ Split History
JUNO Split History
KALV Split History
KBIO Split History
KIDS Split History
KOOL Split History

Also explore: IRWD shares outstanding history

Aviat Networks, Inc. (AVNW)
Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
MicroSectors FANG+ Index 2X Leveraged ETNs due January 8, 2038 (FNGO)
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038 (FNGU)
Moleculin Biotech, Inc. (MBRX)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

IRWD Insider Buying

IRWD Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.